nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Paclitaxel—ovarian cancer	0.0796	0.0796	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Altretamine—ovarian cancer	0.0276	0.0276	CcSEcCtD
Nalidixic Acid—Vertigo—Altretamine—ovarian cancer	0.0198	0.0198	CcSEcCtD
Nalidixic Acid—Leukopenia—Altretamine—ovarian cancer	0.0197	0.0197	CcSEcCtD
Nalidixic Acid—Convulsion—Altretamine—ovarian cancer	0.0191	0.0191	CcSEcCtD
Nalidixic Acid—Blister—Vinorelbine—ovarian cancer	0.0189	0.0189	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Altretamine—ovarian cancer	0.0176	0.0176	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.0144	0.0144	CcSEcCtD
Nalidixic Acid—Asthenia—Altretamine—ovarian cancer	0.0129	0.0129	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Melphalan—ovarian cancer	0.0126	0.0126	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Topotecan—ovarian cancer	0.0121	0.0121	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Topotecan—ovarian cancer	0.012	0.012	CcSEcCtD
Nalidixic Acid—Dizziness—Altretamine—ovarian cancer	0.0119	0.0119	CcSEcCtD
Nalidixic Acid—Vomiting—Altretamine—ovarian cancer	0.0114	0.0114	CcSEcCtD
Nalidixic Acid—Nausea—Altretamine—ovarian cancer	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Vinorelbine—ovarian cancer	0.0104	0.0104	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00994	0.00994	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00982	0.00982	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Topotecan—ovarian cancer	0.00875	0.00875	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Melphalan—ovarian cancer	0.00856	0.00856	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—ovarian cancer	0.00853	0.00853	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Chlorambucil—ovarian cancer	0.00851	0.00851	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—ovarian cancer	0.00789	0.00789	CcSEcCtD
Nalidixic Acid—Swelling—Paclitaxel—ovarian cancer	0.00755	0.00755	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00748	0.00748	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—ovarian cancer	0.00728	0.00728	CcSEcCtD
Nalidixic Acid—Injury—Paclitaxel—ovarian cancer	0.00725	0.00725	CcSEcCtD
Nalidixic Acid—Angioedema—Chlorambucil—ovarian cancer	0.00716	0.00716	CcSEcCtD
Nalidixic Acid—Leukopenia—Chlorambucil—ovarian cancer	0.00701	0.00701	CcSEcCtD
Nalidixic Acid—Convulsion—Chlorambucil—ovarian cancer	0.00679	0.00679	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—ovarian cancer	0.00674	0.00674	CcSEcCtD
Nalidixic Acid—Swelling—Docetaxel—ovarian cancer	0.0064	0.0064	CcSEcCtD
Nalidixic Acid—Angioedema—Topotecan—ovarian cancer	0.00637	0.00637	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00626	0.00626	CcSEcCtD
Nalidixic Acid—Leukopenia—Topotecan—ovarian cancer	0.00624	0.00624	CcSEcCtD
Nalidixic Acid—Leukopenia—Melphalan—ovarian cancer	0.00611	0.00611	CcSEcCtD
Nalidixic Acid—Erythema—Vinorelbine—ovarian cancer	0.00596	0.00596	CcSEcCtD
Nalidixic Acid—Arthralgia—Topotecan—ovarian cancer	0.00594	0.00594	CcSEcCtD
Nalidixic Acid—Convulsion—Melphalan—ovarian cancer	0.00592	0.00592	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Docetaxel—ovarian cancer	0.00591	0.00591	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Topotecan—ovarian cancer	0.00569	0.00569	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Melphalan—ovarian cancer	0.00557	0.00557	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Topotecan—ovarian cancer	0.00557	0.00557	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Melphalan—ovarian cancer	0.00546	0.00546	CcSEcCtD
Nalidixic Acid—Angioedema—Vinorelbine—ovarian cancer	0.00545	0.00545	CcSEcCtD
Nalidixic Acid—Vertigo—Vinorelbine—ovarian cancer	0.00536	0.00536	CcSEcCtD
Nalidixic Acid—Leukopenia—Vinorelbine—ovarian cancer	0.00534	0.00534	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00526	0.00526	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00523	0.00523	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00518	0.00518	CcSEcCtD
Nalidixic Acid—Paraesthesia—Topotecan—ovarian cancer	0.00511	0.00511	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00509	0.00509	CcSEcCtD
Nalidixic Acid—Urticaria—Chlorambucil—ovarian cancer	0.00508	0.00508	CcSEcCtD
Nalidixic Acid—Arthralgia—Vinorelbine—ovarian cancer	0.00508	0.00508	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00508	0.00508	CcSEcCtD
Nalidixic Acid—Abdominal pain—Chlorambucil—ovarian cancer	0.00505	0.00505	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00503	0.00503	CcSEcCtD
Nalidixic Acid—Paraesthesia—Melphalan—ovarian cancer	0.005	0.005	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00487	0.00487	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00477	0.00477	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Topotecan—ovarian cancer	0.00465	0.00465	CcSEcCtD
Nalidixic Acid—Asthenia—Chlorambucil—ovarian cancer	0.00459	0.00459	CcSEcCtD
Nalidixic Acid—Pruritus—Chlorambucil—ovarian cancer	0.00452	0.00452	CcSEcCtD
Nalidixic Acid—Urticaria—Topotecan—ovarian cancer	0.00452	0.00452	CcSEcCtD
Nalidixic Acid—Abdominal pain—Topotecan—ovarian cancer	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Visual impairment—Paclitaxel—ovarian cancer	0.00444	0.00444	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00444	0.00444	CcSEcCtD
Nalidixic Acid—Urticaria—Melphalan—ovarian cancer	0.00443	0.00443	CcSEcCtD
Nalidixic Acid—Diarrhoea—Chlorambucil—ovarian cancer	0.00437	0.00437	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinorelbine—ovarian cancer	0.00437	0.00437	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Paclitaxel—ovarian cancer	0.00436	0.00436	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00431	0.00431	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00427	0.00427	CcSEcCtD
Nalidixic Acid—Asthenia—Topotecan—ovarian cancer	0.00408	0.00408	CcSEcCtD
Nalidixic Acid—Vomiting—Chlorambucil—ovarian cancer	0.00406	0.00406	CcSEcCtD
Nalidixic Acid—Pruritus—Topotecan—ovarian cancer	0.00403	0.00403	CcSEcCtD
Nalidixic Acid—Erythema—Paclitaxel—ovarian cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Asthenia—Melphalan—ovarian cancer	0.004	0.004	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—ovarian cancer	0.00399	0.00399	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00398	0.00398	CcSEcCtD
Nalidixic Acid—Pruritus—Melphalan—ovarian cancer	0.00394	0.00394	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00394	0.00394	CcSEcCtD
Nalidixic Acid—Diarrhoea—Topotecan—ovarian cancer	0.00389	0.00389	CcSEcCtD
Nalidixic Acid—Urticaria—Vinorelbine—ovarian cancer	0.00387	0.00387	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinorelbine—ovarian cancer	0.00385	0.00385	CcSEcCtD
Nalidixic Acid—Diarrhoea—Melphalan—ovarian cancer	0.00381	0.00381	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—ovarian cancer	0.00381	0.00381	CcSEcCtD
Nalidixic Acid—Nausea—Chlorambucil—ovarian cancer	0.0038	0.0038	CcSEcCtD
Nalidixic Acid—Visual impairment—Docetaxel—ovarian cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Dizziness—Topotecan—ovarian cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Docetaxel—ovarian cancer	0.00369	0.00369	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00369	0.00369	CcSEcCtD
Nalidixic Acid—Angioedema—Paclitaxel—ovarian cancer	0.00367	0.00367	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00364	0.00364	CcSEcCtD
Nalidixic Acid—Vomiting—Topotecan—ovarian cancer	0.00362	0.00362	CcSEcCtD
Nalidixic Acid—Vertigo—Paclitaxel—ovarian cancer	0.0036	0.0036	CcSEcCtD
Nalidixic Acid—Leukopenia—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Rash—Topotecan—ovarian cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Dermatitis—Topotecan—ovarian cancer	0.00358	0.00358	CcSEcCtD
Nalidixic Acid—Headache—Topotecan—ovarian cancer	0.00357	0.00357	CcSEcCtD
Nalidixic Acid—Vomiting—Melphalan—ovarian cancer	0.00354	0.00354	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—ovarian cancer	0.00352	0.00352	CcSEcCtD
Nalidixic Acid—Rash—Melphalan—ovarian cancer	0.00351	0.00351	CcSEcCtD
Nalidixic Acid—Dermatitis—Melphalan—ovarian cancer	0.00351	0.00351	CcSEcCtD
Nalidixic Acid—Asthenia—Vinorelbine—ovarian cancer	0.00349	0.00349	CcSEcCtD
Nalidixic Acid—Convulsion—Paclitaxel—ovarian cancer	0.00348	0.00348	CcSEcCtD
Nalidixic Acid—Pruritus—Vinorelbine—ovarian cancer	0.00344	0.00344	CcSEcCtD
Nalidixic Acid—Arthralgia—Paclitaxel—ovarian cancer	0.00342	0.00342	CcSEcCtD
Nalidixic Acid—Erythema—Docetaxel—ovarian cancer	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Nausea—Topotecan—ovarian cancer	0.00338	0.00338	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinorelbine—ovarian cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Nausea—Melphalan—ovarian cancer	0.00331	0.00331	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00327	0.00327	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Nalidixic Acid—Dizziness—Vinorelbine—ovarian cancer	0.00322	0.00322	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00321	0.00321	CcSEcCtD
Nalidixic Acid—Vomiting—Vinorelbine—ovarian cancer	0.0031	0.0031	CcSEcCtD
Nalidixic Acid—Rash—Vinorelbine—ovarian cancer	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Dermatitis—Vinorelbine—ovarian cancer	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Headache—Vinorelbine—ovarian cancer	0.00305	0.00305	CcSEcCtD
Nalidixic Acid—Leukopenia—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—ovarian cancer	0.00302	0.00302	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—ovarian cancer	0.003	0.003	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Nalidixic Acid—Convulsion—Docetaxel—ovarian cancer	0.00295	0.00295	CcSEcCtD
Nalidixic Acid—Paraesthesia—Paclitaxel—ovarian cancer	0.00294	0.00294	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—ovarian cancer	0.00294	0.00294	CcSEcCtD
Nalidixic Acid—Somnolence—Paclitaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Arthralgia—Docetaxel—ovarian cancer	0.0029	0.0029	CcSEcCtD
Nalidixic Acid—Nausea—Vinorelbine—ovarian cancer	0.00289	0.00289	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00288	0.00288	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00278	0.00278	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.00278	0.00278	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—ovarian cancer	0.00272	0.00272	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00269	0.00269	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00268	0.00268	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00266	0.00266	CcSEcCtD
Nalidixic Acid—Urticaria—Paclitaxel—ovarian cancer	0.0026	0.0026	CcSEcCtD
Nalidixic Acid—Abdominal pain—Paclitaxel—ovarian cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—ovarian cancer	0.00254	0.00254	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00253	0.00253	CcSEcCtD
Nalidixic Acid—Paraesthesia—Docetaxel—ovarian cancer	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—ovarian cancer	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Somnolence—Docetaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—ovarian cancer	0.00235	0.00235	CcSEcCtD
Nalidixic Acid—Asthenia—Paclitaxel—ovarian cancer	0.00235	0.00235	CcSEcCtD
Nalidixic Acid—Pruritus—Paclitaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.00231	0.00231	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00227	0.00227	CcSEcCtD
Nalidixic Acid—Diarrhoea—Paclitaxel—ovarian cancer	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Abdominal pain—Docetaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Nalidixic Acid—Dizziness—Paclitaxel—ovarian cancer	0.00217	0.00217	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Nalidixic Acid—Vomiting—Paclitaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Nalidixic Acid—Rash—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Dermatitis—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—ovarian cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Headache—Paclitaxel—ovarian cancer	0.00205	0.00205	CcSEcCtD
Nalidixic Acid—Asthenia—Docetaxel—ovarian cancer	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—ovarian cancer	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Pruritus—Docetaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—ovarian cancer	0.00195	0.00195	CcSEcCtD
Nalidixic Acid—Nausea—Paclitaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Diarrhoea—Docetaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—ovarian cancer	0.00187	0.00187	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—ovarian cancer	0.00184	0.00184	CcSEcCtD
Nalidixic Acid—Dizziness—Docetaxel—ovarian cancer	0.00184	0.00184	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—ovarian cancer	0.00183	0.00183	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Nalidixic Acid—Vomiting—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Nalidixic Acid—Rash—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Nalidixic Acid—Dermatitis—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Nalidixic Acid—Headache—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Nalidixic Acid—Nausea—Docetaxel—ovarian cancer	0.00165	0.00165	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
